scieee Open visual document viewer

RegisPt: registry of registries in Portugal: design, data model, and functionalities

Laires, Pedro,Barros, Vitor

Abstract

ABSTRACT - Introduction: The number and quality of existing patient registries are not known in Portugal. In order to improve the knowledge regarding this issue, an interactive tool (RegisPt) was developed to identify and characterize all available patient registries in our country. This article aims to describe the RegisPt design, data model, and due functionalities. Methods: RegisPt was developed in Microsoft Office Access 2010 and all variables definitions were done according to standardized international classifications. A review of the available literature and web resources was performed in order to identify all relevant patient registries. Results: The RegisPt platform is divided into 5 core modules containing comprehensive information from each patient registry (general data, registry design, characterization, effectiveness, and publications). Effectiveness is of utmost importance for health technology assessment and is divided into 2 sections: the exposure (health care service, pharmaceutical drugs, and medical devices) and the outcomes (safety, clinical, and economic). The RegisPt platform allows adding and editing registries as well as consulting all available registries in an interactive and user-friendly way, using a preferred query (e.g., registry name, institution, and therapeutic area). About 50 patient registries were identified and characterized in Portugal in accordance with the patient registry definition of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Discussion: The RegisPt is a first step to better understand and use the available resources for health research in Portugal. RegisPt can promote collaboration between researchers and registry owners and encourage the efficient use of resources and may improve the access to registries. This project may also be useful to identify therapeutic areas still lacking patient registries and to optimize existing ones in the country, by comparing registry design, quality, and functional strategies. In the future, this valuable platform may be particularly relevant for researchers and authorities aiming to carry out health technology assessment.

Full text

Resea ch A icle Po J Public Heal h 2017;35:126–131 RegisP : Regis y o Regis ies in Po ugal – Design, Da a Model, and Func ionali ies Ped o Lai es a Vi o Ba os b a Cen o de In es igação em Saúde Pública, Escola Nacional de Saúde Pública, Lisbon, Po ugal; b Me ck Sha p & Dohme – Ou comes Resea ch, Lisbon, Po ugal Recei ed: No embe 15, 2016 Accep ed: July 6, 2017 Published online: Decembe 18, 2017 D . Ped o A. Lai es Facul y o Medical Sciences, Lisbon Academic Medical Cen e A . Pad e C uz PT–1600-560 Lisbon (Po ugal) E-Mail lai es.ped o @ gmail.com © 2017 The Au ho (s). Published by S. Ka ge AG, Basel on behal o NOVA Na ional School o Public Heal h E-Mail ka ge @ka ge .com www.ka ge .com/pjp DOI: 10.1159/000479778 Keywo ds Pa ien egis ies · Da abases · Epidemiologic s udies · Heal h echnology assessmen Abs ac In oduc ion: The numbe and quali y o exis ing pa ien egis ies a e no known in Po ugal. In o de o imp o e he knowledge ega ding his issue, an in e ac i e ool (RegisP ) was de eloped o iden i y and cha ac e ize all a ailable pa- ien egis ies in ou coun y. This a icle aims o desc ibe he RegisP design, da a model, and due unc ionali ies. Me hods: RegisP was de eloped in Mic oso O ice Access 2010 and all a iables de ini ions we e done acco ding o s anda dized in e na ional classi ica ions. A e iew o he a ailable li e a u e and web esou ces was pe o med in o - de o iden i y all ele an pa ien egis ies. Resul s: The RegisP pla o m is di ided in o 5 co e modules con aining comp ehensi e in o ma ion om each pa ien egis y (gen- e al da a, egis y design, cha ac e iza ion, e ec i eness, and publica ions). E ec i eness is o u mos impo ance o heal h echnology assessmen and is di ided in o 2 sec ions: he exposu e (heal h ca e se ice, pha maceu ical d ugs, and medical de ices) and he ou comes (sa e y, clinical, and eco- nomic). The RegisP pla o m allows adding and edi ing eg- is ies as well as consul ing all a ailable egis ies in an in e - ac i e and use - iendly way, using a p e e ed que y (e.g., egis y name, ins i u ion, and he apeu ic a ea). Abou 50 pa ien egis ies we e iden i ied and cha ac e ized in Po u- gal in acco dance wi h he pa ien egis y de ini ion o he In e na ional Socie y o Pha macoeconomics and Ou - comes Resea ch (ISPOR). Discussion: The RegisP is a i s s ep o be e unde s and and use he a ailable esou ces o heal h esea ch in Po ugal. RegisP can p omo e collabo a- ion be ween esea che s and egis y owne s and encou - age he e icien use o esou ces and may imp o e he ac- cess o egis ies. This p ojec may also be use ul o iden i y he apeu ic a eas s ill lacking pa ien egis ies and o op i- mize exis ing ones in he coun y, by compa ing egis y de- sign, quali y, and unc ional s a egies. In he u u e, his aluable pla o m may be pa icula ly ele an o esea ch- e s and au ho i ies aiming o ca y ou heal h echnology assessmen . © 2017 The Au ho (s). Published by S. Ka ge AG, Basel on behal o NOVA Na ional School o Public Heal h RegisP : egis o de egis os em Po ugal: desenho, modelo de dados e espe i as uncionalidades Pala as cha e Regis o de doen es · Bases de dados · Es udos epidemiológicos · A aliação de ecnologias da saúde This a icle is licensed unde he C ea i e Commons A ibu ion- NonComme cial-NoDe i a i es 4.0 In e na ional License (CC BY- NC-ND) (h p://www.ka ge .com/Se ices/OpenAccessLicense). Usage and dis ibu ion o comme cial pu poses as well as any dis- ibu ion o modi ied ma e ial equi es w i en pe mission. RegisP : Regis y o Regis ies in Po ugal 127 Po J Public Heal h 2017;35:126–131 DOI: 10.1159/000479778 Resumo In odução: O núme o e a qualidade dos egis os de doen es exis en es em Po ugal não são in ei amen e conhecidos. Com o obje i o de melho a o conhecimen o nes a á ea, oi desen ol ida uma e amen a in e a i a (RegisP ) pa a iden i ica e ca ac e iza odos os egis os de doen es disponí eis no nosso país. Es e a igo de- sc e e a es u u a e o desenho do RegisP , o modelo de dados ecolhidos e as espe i as uncionalidades. Mé o- dos: O RegisP oi desen ol ido em Mic oso O ice Ac- cess 2010 e odas as de inições de a iá eis basea am-se em classi icações in e nacionais. Foi ealizada uma e- isão de li e a u a pa a iden i ica e ca ac e iza odos os egis os de doen es ele an es. Resul ados: A pla a o ma RegisP es á di idida em cinco módulos p incipais que con êm in o mações ab angen es de cada egis o de doen es (Dados Ge ais, Desenho do Regis o, Ca ac e iza- ção, E e i idade e Publicações). Em pa icula , o módulo de E e i idade é de ex ema impo ância pa a a A aliação de Tecnologias em Saúde e es á di idido em duas seções p incipais: Exposição (Se iço de Saúde, Medicamen os e Disposi i os Médicos) e Resul ados (Segu ança, Ou - comes Clínicos e Económicos). A pla a o ma RegisP pe - mi e adiciona e edi a egis os, bem como consul a o- dos os egis os disponí eis de o ma simples e in e a i a, a a és de pesquisas especí icas (po exemplo, nome do egis o, ins i uição e á ea e apêu ica). Ce ca de 50 egis- os de doen es o am iden i icados e ca ac e izados de aco do com a de inição ado ada pela In e na ional Soci- e y o Pha macoeconomics and Ou comes Resea ch (ISPOR). Discussão: O RegisP é um p imei o passo pa a melho en ende e u iliza os ecu sos disponí eis pa a in- es igação em saúde ealizada em Po ugal. O RegisP pode á p omo e a colabo ação en e in es igado es e esponsá eis de egis os, bem como incen i a a u iliza- ção e icien e de ecu sos e melho a o acesso aos egis os já exis en es. Es e p oje o pode á ainda se ú il pa a iden- i ica á eas e apêu icas com lacuna de egis os de doen- es e pa a o imiza aqueles já exis en es. No u u o, es a pla a o ma pode á se pa icula men e ele an e pa a in- es igado es e Au o idades pa a a e icien e implemen a- ção da A aliação de Tecnologias em Saúde em Po ugal. © 2017 The Au ho (s). Published by S. Ka ge AG, Basel on behal o NOVA Na ional School o Public Heal h In oduc ion The Po uguese Na ional Heal h Se ice (NHS) is cu - en ly unde high p essu e o become mo e e icien , by ea ing be e wi h ewe esou ces. This eali y in luenc- es policy make s, esea che s, and heal hca e p o ession- als. I a ec s he whole decision-making p ocess in he heal hca e a ea and all due alloca ion o needed esou ces. Good quali y knowledge abou disease pa e ns and po- en ial in e en ions, such as heal hca e echnologies, is needed in o de o help decide s making easoned and sus ainable decisions abou he u u e o he NHS. Al- hough clinical guidelines and suppo o decision-mak- ing mainly comes om clinical ials and e idence om ab oad, he need o knowing ou own eali y, namely he epidemiologic pa e ns, and he e ec i eness o a ailable policies and in e en ions is inc easing. Mo eo e , a con- sensus exis s on he gene al need o g ea e a ailabili y o eal wo ld da a (RWD) [1]. Regis ies ep esen one o he main sou ces o RWD. The use o egis ies was ini ia ed in he 1930s in he UK and USA as a means o sys ema ically collec da a on can- ce pa ien s [2]. In 1949, he e m “ egis y” was de ined as a “sys em o eco ding equen ly used in he gene al ield o public heal h which se es as a de ice o he ad- minis a ion o p og ams conce ned wi h he long- e m ca e, ollow-up o obse a ion o indi idual cases” [3]. O e he las decades, se e al de ini ions ha e been p o- posed by he Wo ld Heal h O ganiza ion and US Na ion- al Commi ee on Vi al and Heal h S a is ics among o he en i ies [4]. Despi e a ia ions in de ini ion, i is clea ha a egis y in ol es a long- e m, sys ema ic, and o ganized p ocess o collec ing da a, which is d i en by speci ic, p e- de ined aims [1]. Nowadays, he US Agency o Heal h- ca e Resea ch and Quali y (AHRQ) de ines “pa ien eg- is y” as “an o ganized sys em ha uses obse a ional s udy me hods o collec uni o m da a (clinical and o he ) o e alua e speci ied ou comes o a popula ion de ined by a pa icula disease, condi ion, o exposu e, and ha se es one o mo e p ede e mined scien i ic, clinical, o policy pu poses” [4]. In line wi h his de ini ion, he In- e na ional Socie y o Pha macoeconomics and Ou - comes Resea ch (ISPOR) also has i s own de ini ion o “pa ien egis y” [5]. As a di ec esponse o he objec i e se in A icle 14(2) b o he heal hca e Di ec i e 2011/24/EU, he Membe S a es and he Eu opean Commission c ea ed he “PAR- ENT Join Ac ion”, c oss-bo de PA ien REgis ies iNiTia i e o imp o e seconda y use o da a om pa ien egis ies in a c oss-bo de se ing o bo h public heal h Lai es/Ba os Po J Public Heal h 2017;35:126–131 128 DOI: 10.1159/000479778 and esea ch needs. To achie e one o hei objec i es, he PARENT launched an online ool “Regis y o Regis ies (RoR)” a ailable a h p://www.pa en - o .eu wi h he aim o mapping pa ien egis ies in he Eu opean Union wi h he pu pose o suppo ing sea ch and iden i ica ion o a ailable da a sou ces, and exchanging in o ma ion abou na ional bes p ac ices and lessons lea n on pa ien egis ies [1]. O he ini ia i es a e also known, including Regis y o Pa ien Regis ies (RoPR) in he USA. In addi ion, he e a e also se e al o he examples such as DoCDa – Di ec- o y o clinical da abases in he UK [6], Monash Clinical Regis ies in Aus alia [7], Heal h In o ma ion and Qual- i y Au ho i y (HIQA) in I eland, and Sweden Quali y Regis ies in Sweden. Al hough hese in e na ional o ga- niza ions con ain comp ehensi e lis s o pa ien egis- ies, he le el o egis y cha ac e iza ion a ies signi i- can ly ac oss he se e al lis s o pa ien egis ies. In Po ugal, despi e he g owing need o RWD, we s ill do no know exac ly he cu en si ua ion in ou coun y when i comes o pa ien egis ies, namely ega ding he numbe , he quali y, and he clinical a eas al eady co - e ed. The exis ence o a sea chable public websi e (o da- abase) designed speci ically o p o ide in o ma ion abou pa ien egis ies in Po ugal would esul in a sig- ni ican esou ce o imp o ing he e iciency o ou NHS. Essen ially, such a da abase would p e en unnec- essa y duplica ion o egis ies, educe edundancies, iden i y gaps in esea ch and epidemiologic da a, enable esea che s o unde s and he quali y o da a wi hin eg- is ies, suppo esea ch collabo a ions, encou age he e - icien use o esou ces, and imp o e quali y and ans- pa ency in obse a ional esea ch. Thus, in an a emp o imp o e he knowledge o exis ing pa ien egis ies in Po ugal, we de eloped an in e ac i e ool (RegisP ) ha iden i ies and cha ac e izes all a ailable pa ien egis ies in Po ugal. Ul ima ely, a egis y o egis ies may be a majo con ibu ion o boos e idence-based decisions in ou heal hca e sec o . This a icle aims o desc ibe he RegisP design, da a model, and due unc ionali ies. Me hods The RegisP was de eloped in se e al phases. Phase I Iden i ica ion o a iables o be included in RegisP using 2 main guiding documen s: “Regis ies o E alua ing Pa ien Ou - comes: A Use ’s Guide” [4] and “ISPOR Taxonomy o Pa ien Reg- is ies: Classi ica ion, Cha ac e is ics and Te ms” [5]. Phase II Fi e co e modules we e buil in o de o g oup all he p e i- ously selec ed a iables: Gene al Da a This module includes he desc ip ion o he egis y, ele an adminis a i e in o ma ion (e.g., owne ship, main scien i ic con- ac , websi e, and ins i u ional add ess), egis y classi ica ion (i.e., disease, heal h echnology, heal h managemen /heal h se ices), and due clinical and he apeu ic a ea. Addi ionally, his module desc ibes he ype o in es iga o s (e.g., physicians, pha macis s, and o he heal hca e p o essionals), he ype and numbe o si es in ol ed in he egis y, he numbe o en olled pa ien s, and el- e an miles ones, such as he yea when he egis y s a ed. Regis y Design This module iden i ies he da a sou ces used o collec da a in he egis y (e.g., clinician- and/o pa ien - epo ed da a), he main pu pose (e.g., e ec i eness and sa e y moni o ing), and he pa ien s’ eligibili y c i e ia. This module also con ains in o ma ion abou he equency and desc ip ion o he assessmen s and he ype o ou comes ha a e collec ed in he egis y and iden i ies he po en ial esea ch ou pu s ha may be achie ed using i s da a (e.g., pe sis ence s udies, bu den o illness, and cos -e ec i eness analy- sis). Cha ac e iza ion This module is di ided in o 6 sec ions. The i s sec ion aims o lis he socio-demog aphic a iables collec ed by he egis y. The ollowing sec ions agg ega e a iables ela ed wi h quali y o li e and unc ional measu es, occupa ional da a, li es yle, heal hca e access, and clinical da a. All a iables may be cha ac e ized in ac- co dance wi h he momen o da a collec ion (i.e., baseline and ollow-up). E ec i eness This module is di ided in o 2 sec ions. The exposu e sec ion aims o cha ac e ize he a iables ela ed wi h he heal hca e in e - en ion (i.e., heal hca e se ice, pha maceu ical d ugs, and medi- cal de ices). Pha maceu ical d ugs and medical de ices may be selec ed om p ede ined lis s impo ed om INFARMED’s da a- bases (h ps://www.in a med.p /in omed/inicio.php and h ps:// app.in a med.p /dec_hosp/pages/cdmpublic.aspx), which con ain ele an in o ma ion al eady illed in line wi h s anda dized clas- si ica ions (e.g., d ug subs ance, b and name, dosage o m, s eng h, ma ke ing au ho iza ion holde , medical de ice code, and manu ac u e ). The ou comes sec ion aims o cha ac e ize he a iables ela ed wi h he po en ial ou comes ha migh be ana- lyzed ollowing an in e en ion collec ed in a gi en egis y, en- compassing sa e y, e ec i eness (e.g., su oga e ma ke s and p e- speci ied ha d clinical endpoin s), and economic ou comes (e.g., heal hca e esou ce u iliza ion and p oduc i i y losses). Publica ions This module aims o lis all scien i ic publica ions ela ed wi h in o ma ion e ie ed om he egis y. Phase III De elopmen and es ing o he RegisP IT pla o m using Mi- c oso O ice Access 2010. RegisP : Regis y o Regis ies in Po ugal 129 Po J Public Heal h 2017;35:126–131 DOI: 10.1159/000479778 Phase IV Iden i ica ion and cha ac e iza ion o all a ailable Po uguese pa ien egis ies. A e iew o a ailable li e a u e and web esou c- es was pe o med in o de o iden i y and cha ac e ize all pa ien egis ies aking in o conside a ion he a iables selec ed in RegisP . The adop ed c i e ia used o he inclusion o egis ies in he RegisP was he pa ien egis y de ini ion o ISPOR, which de ines a “pa ien egis y” as “a p ospec i e obse a ional s udy o pa ien s, sha ing some common cha ac e is ics o e ime, which collec s ongoing and suppo ing da a on well-de ined ou comes o in e es o analysis and epo ing” [5]. The e we e no u he c i- e ia applied in he selec ion o pa ien egis ies. Phase V In o de o ga he sus ainable suppo om o he ele an en i- ies, impo an pa ne ships we e c ea ed wi h he ollowing ins i- u ions: Fundação Calous e Gulbenkian, Escola Nacional de Saúde Pública, Ins i u o Nacional Rica do Jo ge and Capí ulo Po uguês do ISPOR. A Scien i ic Commi ee was es ablished wi h ep esen- a i es o each pa ne , which will be esponsible o he o e all s a egy, o e sigh , and go e nance o he RegisP . Phase VI Sys ema ic con ac , alida ion, and u he da a inpu by he espec i e egis ies’ owne s in o de o comple e and alida e he RegisP da abase ( his phase is s ill ongoing). Resul s O e 50 pa ien egis ies we e iden i ied in Po ugal acco ding wi h he abo e-men ioned de ini ion o ISPOR. Fu he mo e, du ing he de elopmen and ea ly imple- men a ion o RegisP , abou 60 o he epidemiological da- abases we e ound, which ell ou side his de ini ion. These da abases we e also lis ed and cha ac e ized in hei own eposi o y, labeled “o he da abases” de ined as “o he eco ds/da abases no ul illing he pa ien egis y de ini ion o ISPOR.” The RegisP pla o m allows he addi ion o new eg- is ies and he edi ion o any al eady lis ed, wi hou any access o speci ic pa ien ’s da a. I also allows an in e ac- i e and use - iendly sea ch, using a p e e ed que y (e.g., egis y name, ins i u ion, and he apeu ic a ea). Na iga ion h ough each o he selec ed egis ies is sim- ple and s aigh o wa d. Edi ing o he RegisP pla o m is es ic ed o egis e use s wi h due p i ileges p e i- ously g an ed by he RegisP Scien i ic Commi ee. The sys em is p epa ed o se di e en le els o use p i ileges ( om ead-only o adminis a o igh s). All addi ion o edi ing ac ions done in he RegisP pla o m a e subjec o p io app o al and a e au oma ically no i ied o he Scien i ic Commi ee h ough an e-mail wi h he de ails o pe o med addi ions/edi s. This Commi ee is espon- sible o app o ing o declining any p oposed addi ion/ edi ing done in he sys em. RegisP has a ack eco d sys em in place allowing he Scien i ic Commi ee and he sys em’s adminis a o s o ha e access o he da abase adminis a ion module, whe e hey can iew all pas edi ing pe o med in he RegisP and all decisions ha we e pe o med since he beginning o he RegisP (see online suppl. Fig. 1; see www. ka ge .com/doi/10.1159/000479778 o all online suppl. ma e ial). Discussion The numbe o exis ing pa ien egis ies and hei a ea o in e en ion a e no known in Po ugal. RegisP con- sis in an in e ac i e pla o m ha aims o iden i y and cha ac e ize all a ailable pa ien egis ies in he coun y. This ini ia i e is an ongoing p ojec and un il now, we ha e iden i ied and cha ac e ized abou 50 pa ien egis- ies and 60 o he da abases. RegisP may p omo e collabo a ion be ween esea ch- e s and egis y owne s, encou age he e icien use o e- sou ces, educe edundancy, imp o e he anspa ency in egis y-based esea ch, and acili a e he access o in o - ma ion abou egis ies as well as he o e all quali y o clinical eco ds in Po ugal. This p ojec may also be use- ul o iden i y he apeu ic a eas s ill lacking pa ien egis- ies, o discou age ini ia i es aiming o collec e idence al eady co e ed by o he egis ies, and o op imize exis - ing ones, while making a c i ical con ibu ion in making be e decisions in public heal h. The impo ance o p ojec s like RegisP and o he s a he Eu opean le el ha e al eady been ecognized by e- sea che s, policy make s, and o he s akeholde s, namely o suppo heal h echnology assessmen (HTA) [1, 8]. HTA and pa icula ly heal h economic e alua ions can be use ul ools o help p io i izing new in e en ions, be- cause hey illus a e he cos s and heal h ou comes associ- a ed wi h he di e en in e en ions [9]. In a ime o eco- nomic cons ain s, no all new in e en ions ha a e e - ec i e may be in oduced and/o main ained in he heal hca e sys ems. The e o e, eliable ools ha help his so o analy ical me hods and decisions a e o pa amoun impo ance. T adi ionally, he HTA depends on da a gene a ed by andomized con olled ials and li e a u e e iews on he subjec . Al hough hey a e conside ed as a “gold s an- da d” in clinical e icacy, hese s udies ha e some limi a- ions. Typically, hey a e conduc ed du ing a sho pe i- Lai es/Ba os Po J Public Heal h 2017;35:126–131 130 DOI: 10.1159/000479778 od o ime, in a well-de ined popula ion wi h he aim o es ablishing clinical e icacy and sa e y, wi h speci ic in- clusion and exclusion c i e ia, and unde almos “labo a- o y-like” condi ions [10]. Due o hese me hodological cha ac e is ics, hei esul s canno be ex apola ed o uncon olled en i onmen s as he eal clinical p ac ice [10]. In HTA, da a om egis ies may se e as a sou ce o eal-wo ld e idence abou he “e ec i eness” o ea - men s. Hence, i is clea ha da a om pa ien egis ies can supplemen he da a om andomized con olled ials, because i allows ha ing a mo e ealis ic iew o he ue impac o a gi en ea men in he popula ion (i.e., eal-wo ld ea men e ec ) [10]. The use o pa ien eg- is ies has se e al po en iali ies, such as o obse e he clinical cou se o a disease, o illus a e p ac ice pa e ns and a ia ions o hem, o de e mine clinical e ec i e- ness and/o cos -e ec i eness, o assess sa e y o ha m, o explo e humanis ic ou comes, including heal h- ela - ed quali y o li e and o he pa ien - epo ed ou comes, and o ack economic da a, namely esou ce u iliza ion [8]. Po ugal is no excep ion o he global esou ces sca - ci y scena io and he ein o ced need o ake in o accoun he sus ainabili y o he NHS. This si ua ion has led o he new HTA sys em implemen ed in ou coun y, called “Sis ema Nacional de A aliação de Tecnologias de Saúde” (SiNATS), which in oduced subs an ial changes in he p e ious model o echnology assessmen in heal h. The SiNATS main objec i es a e o maximize heal h gains and he quali y o li e o he ci izens, o con ibu e o sus ain- abili y o he NHS, o gua an ee e icien use o public esou ces in heal h, o moni o he use and echnologies, o educe was e and ine iciencies, o p omo e and ewa d ele an inno a ion de elopmen , and o p omo e equi- able access o echnologies [11]. Among se e al impo an changes o he old model, his new sys em in oduces a eassessmen o echnolo- gies (ex pos e alua ion), based on e ec i eness moni o - ing on pa ien egis ies, showing a pa adigm change in he HTA se ing in Po ugal. Wi hin his new sys em, an in o ma ion sys em o HTA (SiATS – Sis ema de In o - mação pa a a A aliação das Tecnologias de Saúde) was ini ia ed ha aims o moni o all da a sou ces and exis ing pa ien egis ies ha may suppo he assessmen s o new p oduc s in he u u e. SiATS will p io i ize he ollowing pa ien egis ies a a na ional le el: (1) oncology (na ion- al oncologic egis y), (2) HIV/AIDS, (3) a e diseases/ o phan p oduc s, (4) medical de ices (ca diology), and (5) hepa i is C (al eady in use) [11]. In Po ugal, he cu en si ua ion abou exis ing pa- ien egis ies is unknown. Wi hin he amewo k o his new na ional HTA sys em and aking in o accoun he need o pa ien egis ies as da a sou ce o eassessmen o new echnologies in he ma ke , he RegisP can be iewed as an use ul ool o he ac i i y o SiNATS and be used as a s a ing poin o he much needed discussion ega ding he a ailabili y o da a sou ces o he execu ion o hei aims. A guably, RegisP migh be a aluable e- sou ce o SiNATS. O e all, by inc easing he public knowledge o pa ien egis ies, RegisP may con ibu e o accele a ing he mos needed e idence-based decisions in ou heal hca e sec o . Fu u e Pe spec i es Despi e he po en ial bene i s o pa ien egis ies, he e a e some limi a ions ha need o be highligh ed, which in u n in luence i s u iliza ion as a p ima y da a sou ce o eassessmen o echnologies, clinical esea ch, clinical audi , o planning and managemen o clinical se ices. The use o egis ies is no only condi ioned by he lack o knowledge abou hei exis ence/a ailabili y and by he co e age hey ha e, bu also by he quali y o da a included in he egis y. To ou knowledge, he e a e no es ablished guidelines a he in e na ional le el se ing c i e ia and quali y measu es o pa ien egis ies. Ne e - heless, some quali y assessmen checklis s ha e al eady been de eloped, o ins ance in he UK [6], by o he ini- ia i es simila o RegisP based on he app oach used o de elop CONSORT [12], he checklis assessing he qual- i y o andomized ials. Due o he need o high-quali y egis ies, go e nmen al agencies such as he Agency o Heal hca e Resea ch and Quali y [4] o in e na ional so- cie ies such as ISPOR [5] among o he s ha e p epa ed and published dossie s o guide heal hca e o ganiza ions owa ds planning and implemen a ion o new egis ies. On his ega d, he RegisP Scien i ic Commi ee will y o de elop a quali y assessmen checklis based on he a ailable li e a u e and in he expe ience o simila p oj- ec s. This checklis migh hen be applied o all egis ies included in ou da abase. Finally, RegisP will be soon ac- cessible o he scien i ic communi y and he gene al pub- lic h ough a public websi e ha will allow any use o consul all pa ien egis ies iden i ied in Po ugal and o iew all a iables collec ed by each egis y. This may highligh he he apeu ic a eas s ill needing o be co e ed by a pa ien egis y and migh also help o aise he cu - en quali y s anda ds o he ongoing egis ies, no only RegisP : Regis y o Regis ies in Po ugal 131 Po J Public Heal h 2017;35:126–131 DOI: 10.1159/000479778 in e ms o he quali y o da a being collec ed and egis- e ed, bu also ega ding he in e connec i i y wi hin he es ablished egis ies and wi h o he da abases, such as he hospi al and dea h eco ds, which is undoub edly an a ea o imp o e in ou coun y. Acknowledgemen s We would like o acknowledge Paulo Nicola o he c i ical e- ision o his a icle. Re e ences 1 Zale el M, K alj M (eds): Me hodological guidelines and ecommenda ions o e icien and a ional go e nance o pa ien egis ies. Ljubljana: Na ional Ins i u e o Public Heal h; 2015. 2 S o m HH: Cance egis ies in epidemiolog- ic esea ch. Cance Causes Con ol 1996; 7: 299–301. 3 Bellows MT: Case egis e s. Public Heal h Re- po s 1949; 64: 1148–1158. 4 Gliklich R, D eye N, Lea y M (eds): Regis- ies o E alua ing Pa ien Ou comes: A Us- e ’s Guide. 3 d edi ion (In e ne ). Rock ille, MD: Agency o Heal hca e Resea ch and Quali y; 2014. Ci ed 12.10.2016. A ailable om: h p://www.e ec i eheal hca e.ah q. go / egis ies-guide-3.c m. 5 Polygenis D (ed): ISPOR Taxonomy o Pa- ien Regis ies: Classi ica ion, Cha ac e is ics and Te ms. Law ence ille, NJ: In e na ional Socie y o Pha macoeconomics and Ou - comes Resea ch (ISPOR); 2013. 6 Black N, Payne M; on behal o he DoCDa De elopmen G oup: Di ec o y o clinical da- abases: imp o ing and p omo ing hei use. Qual Sa Heal h Ca e 2003; 12: 348–352. 7 Aus alian Commission on Sa e y and Qual- i y in Heal h Ca e. In as uc u e and Techni- cal S anda ds o Aus alian Clinical Quali y Regis ies (In e ne ). Sydney: ACSQHC; 2012. (Ci ed 15.05.2016). A ailable om: h p://www.sa e yandquali y.go .au/wp-con- en /uploads/2012/03/In as uc u e-and- Technical-S anda ds- o -Clinical-Quali y- Regis ies- 1.0-May-2012.pd . 8 C oss-bo de Pa ien Regis ies iNiTia i e (PARENT). Pa ien Regis ies as Suppo Mechanism o C oss-Bo de Heal hca e Di- ec i e implemen a ion and Fu u e Policy Ac- ions. B ussels: Eu opean Commission. PAR- ENT; 2016. (WP6 Final Repo D8). 9 Doupi P, Klemp M, Goe sch W, P is as I: Pa- ien egis ies as ins umen s o HTA ou - comes esea ch: a Eu opean pe spec i e. Val- ue and Ou comes Spo ligh 2016; 2: 12–15. 10 Dang A, Angle VS: U ilizing pa ien egis ies as heal h echnology assessmen (HTA) ool. Sys Re Pha m 2015; 6: 5–8. 11 Ma ins J: New HTA and p ices and eim- bu semen sys em (SiNATS) in Po ugal: im- pac on he eimbu semen o oncologic med- icines; in IHF Chicago 2015: 39 h Wo ld Hos- pi al Cong ess, Chicago, Illinois USA, Oc obe 6–8, 2015. Be nex: In e na ional Hospi al Fede a ion; 2015. 12 Mohe D, Schulz K, Al man D: The CON- SORT s a emen : e ised ecommenda ions o imp o ing he quali y o epo s o pa al- lel-g oup andomized ials. JAMA 2001; 285: 1987–1991.